Načítá se...
Intravitreal injection of tissue plasminogen activator for central retinal vein occlusion.
PURPOSE: This pilot study evaluated the feasibility of intravitreal injections of tissue plasminogen activator (tPA) in eyes with central retinal vein occlusion (CRVO). METHODS: Between August 1997 and October 2000, 9 eyes with CRVO were treated with intravitreal injection of tPA, 100 micrograms (50...
Uloženo v:
| Hlavní autoři: | , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2001
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1359013/ https://ncbi.nlm.nih.gov/pubmed/11797310 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|